The Consolidation Wave:
Implications for Standalone Hospitals Beyond Metros
Overview
India’s healthcare delivery sector is undergoing a rapid transformation, fueled by strong demand fundamentals and a wave of aggressive consolidation. In FY23, the sector accounted for over 50% of the country’s USD 216 billion healthcare ecosystem and is projected to grow at a CAGR of 18%. This growth is fueled by rising life expectancy, increasing burden of chronic illness, higher insurance penetration, growing health awareness and India’s growing global reputation for delivering cost-effective, complex medical procedures.. These factors together are pushing demand for better healthcare services, especially in Tier II+ cities, which have now started to emerge as the next major growth frontier.
This surge in demand has also led to a sharp rise in consolidation across the Indian hospital sector. Between FY20 and FY24, the market capitalization of the Hospital sector surged ~9x from USD 4.5 billion to USD 42 billion. A key driver behind this surge has been the rise in M&A transactions.. As large corporate hospital networks actively expand their footprints. In 2024 alone, the sector witnessed deals worth USD 6.1 billion, marking a 24% Y-o-Y growth. Between 2022 and 2024, total M&A value stood at USD 6.76 billion, alongside cumulative private equity inflow of USD 5 billion. The Foreign Direct Investment (FDI) in healthcare and diagnostics touched ~USD 3.2 billion during the same period — a clear signal of rising global investor interest in India’s fast-evolving healthcare landscape.
Before delving deeper into the M&A consolidation trend, let’s take a look at some of the notable transactions that happened in the Indian Healthcare Market in the past few years.
Why Tier II+ Cities Are Becoming the Next Healthcare Hotspots
The hospital sector is undergoing a paradigm shift, with corporate chains increasingly targeting Tier II and Tier III Cities for expansion. Once considered peripheral, these geographies are now emerging as high-potential zones for sustainable growth and long-term dominance. This shift is not incidental yet a calculated response to the favourable conditions that smaller cities now offer.
Key factors fueling this strategic shift:
-
Demand-Supply Gap in Quality Healthcare: Tier II+ cities lack access to advanced medical infrastructure despite growing population and rising disease burden. This underserved demand creates a ripe opportunity for organised players to step in and bridge this critical gap.
-
Cost Advantage and Easier Scalability: Lower real estate costs and affordable workforce and reduced operational expenses make it financially viable for large chains to scale faster in these regions compared to saturated metropolitan markets.
Limited Competition & First Mover Advantage : Tier I cities are already mature, now the focus has shifted towards Tier II cities and the consolidation has already started at a faster pace. These smaller cities offer the chance for the hospital chains to establish brand loyalty early to dominate the local healthcare ecosystem with minimal resistance.
EVERNILE
Evernile Group
Legal
Careers
Copyright © 2025 Evernile. All Rights Reserved.